Asthma treatment at home for Newcastle patients

Patients with severe asthma are to receive a life-changing new treatment at home thanks to clinicians at Newcastle’s Freeman Hospital.

Deemed a UK first, the mepolizumab drug is now being offered for patients to administer at-home through a pre-filled pen or syringe, having usually needed to be administered by a healthcare professional to patients every four weeks.

Mepolizumab is used to treat asthma in patients with eosinophilic asthma, a rare type of asthma which is commonly seen in people who develop asthma in adulthood, although it can occur in children.

John Davison, Senior Nurse Specialist for complex lung disease at The Newcastle upon Tyne Hospitals NHS Foundation Trust said: “We are delighted to be the first Trust in the UK to provide patients with this treatment in the comfort of their own home. Severe asthma patients often struggle to manage everyday activities, and frequent visits to a healthcare professional in hospital can be an added burden for them. This innovation will empower healthcare professionals and patients with greater flexibility to choose a treatment setting that best fits patients’ needs.”

Of the 5.4 million people with asthma in UK, roughly 250,000 adults and children have severe asthma.

Event Diary

This story was first published in digitalhealth.net

Supplier Profiles

CDC success at Victoria Infirmary, Northwich creates ideal model for future patient pathway reforms

Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients

Gain valuable insight with Adveco for gas to electric decarbonisation projects

Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho